ZIOPHARM ONCOLOGY INC·4

Jan 31, 4:51 PM ET

MAUNEY DAVID M MD 4

4 · ZIOPHARM ONCOLOGY INC · Filed Jan 31, 2020

Insider Transaction Report

Form 4
Period: 2020-01-29
MAUNEY DAVID M MD
EVP and Chief Business Officer
Transactions
  • Award

    Common Stock

    2020-01-29+80,500275,778 total
  • Award

    Employee Stock Option (right to buy)

    2020-01-29+123,900123,900 total
    Exercise: $4.21Exp: 2030-01-29Common Stock (123,900 underlying)
Footnotes (2)
  • [F1]26,834 shares shall vest on 12/31/2020 and 26,833 shares shall vest on each of 12/31/2021 and 12/31/2022.
  • [F2]1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION